Lora Picton

7PUBLICATIONS
64CO-AUTHORS
Biologically active moleculesRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

Grayson E Rodriguez, Yang Zhao, Yoko Nishiga

|Nov 15, 2022
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors.

Anusha Kalbasi, Mikko Siurala, Leon L Su

|Jun 08, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptors.

Anusha Kalbasi, Mikko Siurala, Leon L Su

|May 19, 2022
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors.

Natalie K Wolf, Cristina Blaj, Lora K Picton

|Mar 25, 2022
Design of protein-binding proteins from the target structure alone.

Longxing Cao, Brian Coventry, Inna Goreshnik

|Dec 22, 2021
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia.

Qian Zhang, Morgan E Hresko, Lora K Picton

Pageof 2